Human Anti-SARS-CoV-2 Immunoglobulin(pH4, Sinopharm)
COVID-19人免疫球蛋白（pH4，国药集团）
Report date: 2024/01/02 20:03:52
Base Information
Drug NameHuman Anti-SARS-CoV-2 Immunoglobulin(pH4, Sinopharm)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSinopharm Wuhan Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSinopharm Wuhan Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A